Skip to content
10-Q

Quarterly Report

bluebird bio, Inc.

0001293971-24-000058

← back to feed
Filed
Sep 27, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Sep 25, 2024 193.91M sh
Shares Diluted Q2 2024 · Jun 30, 2024 193.72M sh
Shares Diluted Q2 2024 · Jun 30, 2024 193.43M sh
Shares Diluted Q2 2024 · Jun 30, 2023 108.69M sh
Shares Diluted Q2 2024 · Jun 30, 2023 105.82M sh
Capex Q2 2024 · Jun 30, 2024 $1.83M
Capex Q2 2024 · Jun 30, 2023 $937K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$140.93M
Operating Cash Flow restated Q2 2024 · Jun 30, 2023 −$130.86M
Short Term Debt Q2 2024 · Jun 30, 2024 $69.84M
Short Term Debt Q2 2024 · Dec 31, 2023 $0
Cash And Equivalents Q2 2024 · Jun 30, 2024 $144.07M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $221.76M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $172.87M
Stockholders Equity Q2 2024 · Jun 30, 2024 $52.98M
Stockholders Equity Q2 2024 · Mar 31, 2024 $131.05M
Stockholders Equity Q2 2024 · Dec 31, 2023 $194.54M
Stockholders Equity restated Q2 2024 · Jun 30, 2023 $234.82M
Stockholders Equity restated Q2 2024 · Mar 31, 2023 $290.42M
Stockholders Equity restated Q2 2024 · Dec 31, 2022 $134.33M
Current Liabilities Q2 2024 · Jun 30, 2024 $297.93M
Current Liabilities Q2 2024 · Dec 31, 2023 $200.11M
Total Liabilities Q2 2024 · Jun 30, 2024 $492.21M
Total Liabilities Q2 2024 · Dec 31, 2023 $424.62M
Current Assets Q2 2024 · Jun 30, 2024 $203.52M
Current Assets Q2 2024 · Dec 31, 2023 $281.69M
Total Assets Q2 2024 · Jun 30, 2024 $545.19M
Total Assets Q2 2024 · Dec 31, 2023 $619.16M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.42
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.78
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$0.58
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$0.41
Eps Basic Q2 2024 · Jun 30, 2024 −$0.42
Eps Basic Q2 2024 · Jun 30, 2024 −$0.78
Eps Basic restated Q2 2024 · Jun 30, 2023 −$0.58
Eps Basic restated Q2 2024 · Jun 30, 2023 −$0.41
Sga Expense Q2 2024 · Jun 30, 2024 $50.39M
Sga Expense Q2 2024 · Jun 30, 2024 $96.71M
Sga Expense restated Q2 2024 · Jun 30, 2023 $40.46M
Sga Expense restated Q2 2024 · Jun 30, 2023 $77.93M
Rd Expense Q2 2024 · Jun 30, 2024 $25.16M
Rd Expense Q2 2024 · Jun 30, 2024 $50.24M
Rd Expense restated Q2 2024 · Jun 30, 2023 $31.45M
Rd Expense restated Q2 2024 · Jun 30, 2023 $73.04M
Net Income Q2 2024 · Jun 30, 2024 −$81.39M
Net Income Q2 2024 · Jun 30, 2024 −$151.2M
Net Income Q2 2024 · Mar 31, 2024 −$69.8M
Net Income restated Q2 2024 · Jun 30, 2023 −$62.79M
Net Income restated Q2 2024 · Jun 30, 2023 −$43.86M
Net Income restated Q2 2024 · Mar 31, 2023 $18.93M
Operating Income Q2 2024 · Jun 30, 2024 −$88.39M
Operating Income Q2 2024 · Jun 30, 2024 −$167.09M
Operating Income restated Q2 2024 · Jun 30, 2023 −$71.72M
Operating Income restated Q2 2024 · Jun 30, 2023 −$60.97M
Gross Profit Q2 2024 · Jun 30, 2024 −$12.85M
Gross Profit Q2 2024 · Jun 30, 2024 −$20.14M
Gross Profit restated Q2 2024 · Jun 30, 2023 $193K
Gross Profit restated Q2 2024 · Jun 30, 2023 −$2.94M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $28.95M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $54.81M
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $6.7M
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $12.21M
Revenue Q2 2024 · Jun 30, 2024 $16.1M
Revenue Q2 2024 · Jun 30, 2024 $34.66M
Revenue Q2 2024 · Jun 30, 2023 $6.84M
Revenue Q2 2024 · Jun 30, 2023 $9.13M